53 related articles for article (PubMed ID: 38306124)
1. Integrating 40-GEP Testing to Improve Clinical Recommendations for Adjuvant Radiation for Cutaneous Squamous Cell Carcinoma: Multidisciplinary Consensus Guidelines.
Gopal R; Marquardt M; Singh G; Tolkachjov SN; Arron ST
J Clin Aesthet Dermatol; 2024 Mar; 17(3 Suppl 2):S3-S8. PubMed ID: 38495846
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.
Wang J; Harwood CA; Bailey E; Bewicke-Copley F; Anene CA; Thomson J; Qamar MJ; Laban R; Nourse C; Schoenherr C; Treanor-Taylor M; Healy E; Lai C; Craig P; Moyes C; Rickaby W; Martin J; Proby C; Inman GJ; Leigh IM
J Am Acad Dermatol; 2023 Dec; 89(6):1159-1166. PubMed ID: 37586461
[TBL] [Abstract][Full Text] [Related]
3. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Wysong A; Somani AK; Ibrahim SF; Cañueto J; Fitzgerald AL; Siegel JJ; Prasai A; Goldberg MS; Farberg AS; Regula C; Bar A; Kasprzak J; Brodland DG; Koyfman SA; Arron ST
Dermatol Ther (Heidelb); 2024 Mar; 14(3):593-612. PubMed ID: 38424384
[TBL] [Abstract][Full Text] [Related]
4. Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance.
Moody BR; Farberg AS; Somani AK; Taylor WA
Dermatol Ther (Heidelb); 2024 Apr; 14(4):861-873. PubMed ID: 38521873
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding as a risk factor for lymph node metastases in cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Gil-Pallares P; Gil-Pallares ME; Navarro-Bielsa A; Figueroa-Silva O; Taboada-Paz L; Suárez-Peñaranda JM
Clin Exp Dermatol; 2024 Apr; ():. PubMed ID: 38687870
[TBL] [Abstract][Full Text] [Related]
6. A Practical Algorithm Integrating Skin Care With Nonenergy and Injectable Dermatologic Procedures to Improve Patient Outcomes and Satisfaction.
Lain E; Andriessen A; Campos VB; Fabi SG; Ginn L; Haus A; Harvey VM; Tremblay JF
J Drugs Dermatol; 2024 Apr; 23(4):227-232. PubMed ID: 38564400
[TBL] [Abstract][Full Text] [Related]
7. Skin Tone Representation on Patient-Facing Skin Cancer Education Websites.
Sadur A; Nasseri M; McCormick ET; Friedman A
J Drugs Dermatol; 2024 May; 23(5):e137-e138. PubMed ID: 38709691
[TBL] [Abstract][Full Text] [Related]
8. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
J Drugs Dermatol; 2024 Feb; 23(2):54-60. PubMed ID: 38306124
[TBL] [Abstract][Full Text] [Related]
9. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
J Drugs Dermatol; 2023 Dec; 22(12):7691. PubMed ID: 38051842
[TBL] [Abstract][Full Text] [Related]
10. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Burshtein J; Shah M; Zakria D; Lockshin B; Crowley J; Merola JF; Gordon K; Shahriari M; Korman NJ; Chovatiya R; Kalb R; Lebwohl M
Dermatol Ther (Heidelb); 2024 Feb; 14(2):323-339. PubMed ID: 38340237
[TBL] [Abstract][Full Text] [Related]
12. Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Hooper PB; Farberg AS; Fitzgerald AL; Siegel JJ; Rackley BB; Prasai A; Kurley SJ; Goldberg MS; Litchman GH
Cancer Invest; 2022 Nov; 40(10):911-922. PubMed ID: 36073945
[TBL] [Abstract][Full Text] [Related]
13. Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma Management.
Arron ST; Blalock TW; Guenther JM; Hyams DM; Ibrahim SF; Koyfman SA; Wysong A
J Drugs Dermatol; 2021 Jun; 20(6):5s-s11. PubMed ID: 34076385
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
